Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07206069 · ClinicalTrials.gov registry record · NA

Telemedicine to Support Living Kidney Donor Candidates

A NA study of Healthy and Living Kidney Donation, sponsored by University of California, Irvine.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT07206069: Recruiting NA study of Healthy and Living Kidney Donation, sponsored by University of California, Irvine.

NCT07206069 is a NA study of Healthy and Living Kidney Donation that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 70 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07206069, a NA study of Healthy and Living Kidney Donation, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this feasibility clinical trial is to learn if telemedicine can be used to provide education and evaluation and counseling for people who are considering living kidney donation. The study will also learn how participants improve decision-making about living kidney donation. The main questions to answer are: * Is telemedicine a practical way to facilitate donor education and evaluation and counseling? * Does telemedicine shared decision making help improve donor candidate decision and engagement during the donor evaluation process? Researchers will compare standard care with a telemedicine care coordination approach. Participants will: \- Receive either standard care or telemedicine video visits to support shared decision making.

Primary Outcome

Proportion of eligible participants who consent and enroll in the study, calculated as the number enrolled divided by the number of eligible participants approached.

Interventions

  • BEHAVIORAL Standard Care (in control arm)
  • BEHAVIORAL Telemedicine Shared Decision-Making

Study Locations (1)

California

  • University of California Irvine Medical Center - Orange

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-10-10
Est. Completion 2026-11-30
Phase NA
University of California, Irvine

368 total trials

What NCT07206069 shows while recruiting

NCT07206069 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Standard Care (in control arm) is the first listed.

NCT07206069 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07206069 about?

NCT07206069 is a clinical study titled "Telemedicine to Support Living Kidney Donor Candidates". The goal of this feasibility clinical trial is to learn if telemedicine can be used to provide education and evaluation and counseling for people who are considering living kidney donation. The study will also learn how participants improve decision-making about living kidney donation. The main ques...

What is the current status of trial NCT07206069?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-10-10. Estimated completion is 2026-11-30.

What conditions does trial NCT07206069 study?

This clinical trial studies the following conditions: Healthy, Living Kidney Donation.

What interventions are being tested in trial NCT07206069?

The interventions under investigation include: Standard Care (in control arm) (BEHAVIORAL), Telemedicine Shared Decision-Making (BEHAVIORAL).

Who is sponsoring clinical trial NCT07206069?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07206069 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07206069's enrollment target sits among peer trials

70 325th of 1090 higher than 759 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07206069, the US trial registry maintained by the National Library of Medicine. NCT07206069 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.